X
Chiron Real Estate Inc.
XRNCIK 0001533615NYSEAcceleratedReal Estate Investment TrustsMarylandFY ends Dec 31
Period
FY 2025
Revenue
$148.21M
Net Income
$-6.88M
Total Assets
$1.24B
Equity
$509.77M
Shares Out
13.23M
Op. Cash Flow
$73.61M
Business
Global Medical REIT Inc. is an internally managed REIT that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems. It provides ownership, leasing and property-management services for medical office buildings, inpatient rehabilitation facilities and other specialized healthcare properties, typically under triple-net leases with some multi-tenant structures. Its operations include holding properties through an operating partnership and participating in a joint venture to source and manage assets. It focuses on U.S. secondary and suburban markets and distributes space via long-term leases to healthcare operators.
Summary from filing dated 2025-02-28
Financials
Consolidated Statement of Income
Year Ended · In millions, except per-share amounts
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Rental revenue | 148 | 138 | 141 | 137 | 116 | |
| Other income | 526,000 | 370,000 | 115,000 | 116,000 | 132,000 | |
| Total revenue | 148 | 139 | 141 | 137 | 116 | |
| General and administrative | 20 | 21 | 17 | 17 | 16 | |
| Operating expenses | 33 | 29 | 28 | 25 | 15 | |
| Depreciation expense | 44 | 40 | 41 | 40 | 34 | |
| Amortization expense | 15 | 15 | 17 | 17 | 13 | |
| Interest expense | 32 | 29 | 31 | 25 | — | |
| Transaction expense | 0 | 155,000 | 44,000 | 354,000 | 151,000 | |
| Total expenses | 143 | 135 | 134 | 124 | — | |
| Income before other income (expense) | 5 | 4 | 7 | 13 | 17 | |
| Gain on sale of investment properties | 1 | 4 | 16 | 7 | 1 | |
| Impairment of investment properties | −13 | −2 | 0 | 0 | — | |
| Equity loss from unconsolidated joint venture | −150,000 | −20,000 | 0 | 0 | — | |
| Loss on extinguishment of debt | 0 | 0 | −868,000 | 0 | 0 | |
| Net (loss) income | −7 | 7 | 22 | 20 | 18 | |
| Less: Preferred stock dividends | −6 | −6 | −6 | −6 | −6 | |
| Less: Net loss (income) attributable to noncontrolling interest | 1 | −59,000 | −1 | −854,000 | −720,000 | |
| Net (loss) income attributable to common stockholders | −12 | 811,000 | 15 | 13 | 12 | |
| Net (loss) income attributable to common stockholders per share - basic | −0.91 | 0.06 | 1.13 | 0.2 | 0.19 | |
| Net (loss) income attributable to common stockholders per share - diluted | −0.91 | 0.06 | 1.13 | 0.2 | 0.19 | |
| Weighted average shares outstanding - basic | 13 | 13 | 13 | 65 | 61 | |
| Weighted average shares outstanding - diluted | 13 | 13 | 13 | 65 | 61 |
Consolidated Balance Sheet
As of · In millions, except per-share amounts
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Land | 170 | 174 | 164 | 168 | 152 | |
| Building | 1,072 | 1,044 | 1,036 | 1,080 | 985 | |
| Site improvements | 26 | 24 | 22 | 22 | 19 | |
| Tenant improvements | 80 | 70 | 66 | 66 | 59 | |
| Acquired lease intangible assets | 145 | 139 | 139 | — | — | |
| Investment in real estate, Total | 1,493 | 1,451 | 1,427 | 1,484 | 1,343 | |
| Less: accumulated depreciation and amortization | −338 | −289 | −248 | −198 | −143 | |
| Investment in real estate, net | 1,155 | 1,162 | 1,179 | 1,286 | 1,200 | |
| Cash and cash equivalents | 9 | 7 | 1 | 4 | 7 | |
| Restricted cash | 3 | 2 | 5 | 10 | 6 | |
| Tenant receivables, net | 7 | 7 | 7 | 8 | 6 | |
| Escrow deposits | 556,000 | 711,000 | 673,000 | 8 | 6 | |
| Deferred assets | 29 | 28 | 27 | 30 | 25 | |
| Derivative assets | 6 | 19 | 25 | 35 | 1 | |
| Goodwill | 6 | 6 | 6 | 6 | 6 | |
| Investment in unconsolidated joint venture | 2 | 2 | — | — | — | |
| Other assets | 25 | 22 | 16 | 7 | — | |
| Total assets | 1,242 | 1,256 | 1,268 | 1,393 | 1,263 | |
| Credit Facility, net of unamortized debt issuance costs of $10,476 and $4,868 at December 31, 2025, and December 31, 2024, respectively | 653 | 632 | 585 | 636 | 515 | |
| Notes payable, net of unamortized debt issuance costs of $0 and $22 at December 31, 2025, and December 31, 2024, respectively | 1 | 14 | 26 | 58 | 57 | |
| Accounts payable and accrued expenses | 18 | 16 | 13 | 14 | 10 | |
| Dividends payable | 12 | 17 | 16 | 16 | 16 | |
| Security deposits | 3 | 3 | 4 | 5 | 5 | |
| Other liabilities | 19 | 14 | 13 | 7 | 8 | |
| Acquired lease intangible liability, net | 5 | 4 | 5 | 8 | 8 | |
| Total liabilities | 712 | 701 | 662 | 744 | 626 | |
| Commitments and Contingencies | — | — | — | — | — | |
| Preferred stock, $0.001 par value, 10,000 shares authorized; 5,155 shares and 3,105 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively (liquidation preference of $128,875 and $77,625 at December 31, 2025 and December 31, 2024, respectively) | 124 | 75 | 75 | 75 | 75 | |
| Common stock, $0.001 par value, 100,000 shares authorized; 13,235 shares and 13,374 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively | 13,000 | 13,000 | 66,000 | 66,000 | 65,000 | |
| Additional paid-in capital | 730 | 734 | 722 | 722 | 711 | |
| Accumulated deficit | −350 | −294 | −239 | −199 | −157 | |
| Accumulated other comprehensive income | 6 | 19 | 25 | 35 | −7 | |
| Total Chiron Real Estate stockholders' equity | 510 | 534 | 584 | 633 | 623 | |
| Noncontrolling interest | 20 | 22 | 22 | 16 | 15 | |
| Total equity | 530 | 556 | 606 | 649 | 638 | |
| Total liabilities and equity | 1,242 | 1,256 | 1,268 | 1,393 | 1,263 |
Consolidated Statement of Cash Flows
Year Ended · In millions, except per-share amounts
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Amortization of acquired lease intangible assets | 14 | 14 | 17 | 17 | 13 | |
| Amortization of above market leases, net | 648,000 | 1 | 1 | 1 | 520,000 | |
| Amortization of debt issuance costs and other | 3 | 2 | 2 | 2 | 2 | |
| Stock-based compensation expense | 4 | 5 | 4 | 5 | 6 | |
| Capitalized preacquisition and other costs charged to expense | 136,000 | 242,000 | 177,000 | 472,000 | 168,000 | |
| Reserve for uncollectible accounts, net | — | 822,000 | 852,000 | 0 | 183,000 | |
| Loss on extinguishment of debt | — | — | 868,000 | — | — | |
| Other | 147,000 | 136,000 | 433,000 | 21,000 | 62,000 | |
| Tenant receivables | 199,000 | −1 | 426,000 | −3 | −657,000 | |
| Deferred assets | −1 | −2 | −3 | −4 | −5 | |
| Other assets and liabilities | 5,000 | 2 | 542,000 | 586,000 | 12,000 | |
| Accounts payable and accrued expenses | 3 | 3 | −2 | 4 | 2 | |
| Security deposits | 124,000 | −364,000 | −2 | 921,000 | 200,000 | |
| Net cash provided by operating activities | 74 | 70 | 68 | 77 | 69 | |
| Purchase of land, buildings, and other tangible and intangible assets and liabilities | −71 | −82 | −442,000 | −151 | −192 | |
| Net proceeds from sale of investment properties | 23 | 57 | 79 | 18 | 5 | |
| Investment in unconsolidated joint venture | — | −2 | — | — | — | |
| Distribution of capital from unconsolidated joint venture | 135,000 | — | — | — | — | |
| Escrow deposits for purchase of properties | 290,000 | −290,000 | — | 98,000 | 2 | |
| Advances received from (made to) related parties | 108,000 | −77,000 | 7,000 | −38,000 | −60,000 | |
| Capital expenditures on existing real estate investments | −11 | −13 | −10 | −5 | — | |
| Leasing commissions | −2 | −6 | −1 | — | — | |
| Net cash (used in) provided by investing activities | −60 | −46 | 68 | −137 | −195 | |
| Net proceeds received from common equity offerings | — | 11 | — | 10 | 206 | |
| Net proceeds received from preferred stock offering | 49 | — | — | — | — | |
| Escrow deposits required by third party lenders | — | 252,000 | 7 | −2 | −3 | |
| Repayment of notes payable | −13 | −12 | −1 | −1 | −8 | |
| Repayment of CMBS loan defeasance | — | — | −32 | — | — | |
| Proceeds from Credit Facility | 138 | 144 | 83 | 139 | 222 | |
| Repayment of Credit Facility | −112 | −100 | −136 | −16 | −224 | |
| Payment of debt issuance costs | −9 | — | −13,000 | −3 | −6 | |
| Repurchase of common stock | −6 | — | — | — | — | |
| Dividends paid to common stockholders, and OP Unit and LTIP Unit holders | −52 | −60 | −59 | −58 | −53 | |
| Dividends paid to preferred stockholders | −6 | −6 | −6 | −6 | −6 | |
| Net cash provided by financing activities | −10 | −22 | −144 | 62 | 128 | |
| Net increase (decrease) in cash and cash equivalents and restricted cash | 3 | 2 | −8 | 2 | 2 | |
| Cash payments for interest | 28 | 27 | 30 | 22 | 18 | |
| Accrued dividends payable | 12 | 17 | 16 | 16 | 16 | |
| Interest rate swap agreements fair value change recognized in other comprehensive (loss) income | −13 | 7 | 10 | −41 | −12 | |
| LTIP Units and OP Units redeemed for common stock | 1 | 910,000 | 427,000 | 682,000 | 1 | |
| Accrued capital expenditures and leasing commissions included in accounts payable and accrued expenses | 1 | 2 | 2 | 1 | 1 | |
| Recognition of lease liability related to right of use asset | 6 | — | 5 | — | — | |
| Write off of unamortized debt issuance costs from loan defeasance | — | — | 240,000 | — | — |
Filings
Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro
Material Events
Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro
Insiders
Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro
Institutional Holders
Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro